Seeking Alpha

BofA weighs in on Amgen (AMGN +1.1%) after digesting recent events related to the firm including...

BofA weighs in on Amgen (AMGN +1.1%) after digesting recent events related to the firm including its planned buyback of $5B worth of stock. Analysts cite prescription sales trends and a favorable dollar/euro climate as drivers, as they slot in 2012 EPS at $6.13 vs. the Street's $5.82.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs